Article information
Full text is only aviable in PDF
References
[1.]
W. Taylor, D. Gladman, P. Helliwell, A. Marchesoni, P. Mease, H. Mielants, and the CASPAR study group.
Classification criteria for psoriatic arthritis. Development of new criteria from a large international study.
Arthritis Rheum, 54 (2006), pp. 2665-2673
[2.]
W. Taylor, H. Zmierczack, P. Helliwell.
Problems with the definition of axial and peripheral disease patterns in psoriatic artritis.
J Rheumatol, 32 (2005), pp. 974-977
[3.]
A. Kavanaugh, C. Ritchlin.
The GRAPPA treatment guideline committee. A systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines.
J Rheumatol, 33 (2006), pp. 1417-1421
[4.]
J. Fransen, C. Antoni, P. Mease, W. Uter, A. Kavanaugh, J. Kalden, et al.
Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumor necrosis fator inhibitors.
Ann Rheum Dis, 65 (2006), pp. 1373-1378
[5.]
B. Leeb, I. Andel, J. Sautner, C. Fassi, T. Nothnagl, B. Rintelen.
The disease activity score in 28 joints in rheumatoid arthritis and psoriatic arthritis patients.
Athritis Rheum (Arthritis Care and Research), 57 (2007), pp. 256-260
[6.]
Fernández Sueiro JL, Willisch Domínguez A, Pinto J, Pértega S, Freire M, Fernández C, et al. ¿Son utiles las medidas de evaluación de la espondilitis anquilosante en las formas axiales de la artritis psoriásica? [abstract]. XXXIII Congreso de la Sociedad Española de Reumatología; Granada, 2007.
[7.]
W. Taylor, W. Harrison.
Could the bath ankylosing spondylitis disease activity index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis.
Arthritis Rheum (Arthritis Care and Research), 51 (2004), pp. 311-315
[8.]
Fernández Sueiro JL, Willisch A, Pinto J, Pértega S, Freire M, Fernández C, et al. Formas axiales de la artritis psoriásica: estudio comparativo con la espondilitis anquilosante primaria [abstract]. XXXIII Congreso de la Sociedad Española de Reumatología; Granada, 2007.
[9.]
Fernández Sueiro JL, Willisch A, Pinto J, Pértega S, Freire M, Galdo F, et al. Prevalence and location of enthesitis in ankylosing spondylitis and psoriatic arthritis [abstract]. Annual European Congress of Rheumatology, EULAR 2007; Barcelona, 2007.
[10.]
W. Boehncke, J. Prinz, A. Gottlieb.
Biologic therapies for psoriasis. A systematic review.
J Rheumatol, 33 (2006), pp. 1447-1451
[11.]
S. Cassell, J. Bieber, P. Rich, Z. Tutuncu, S. Lee, K. Kalunian, et al.
A modified nail psoriasis severity index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis.
J Rheumatol, 43 (2007), pp. 123-129
[12.]
P. Mease, A. Menter.
Quality of life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspective.
Am J Acad Dermatol, 54 (2006), pp. 685-704
Copyright © 2007. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología
